bimatoprost 0.01%
bimatoprost 0.01% is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
A Study of Bimatoprost 0.01% in the Clinical Setting
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Clinical Trials (9)
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
A Study of Bimatoprost 0.01% in the Clinical Setting
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
A Study of LUMIGAN® RC in the Clinical Setting
Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9